“The findings demonstrate the potential for this new cannabis derivative in the treatment of both localized and advanced pancreatic cancer,” the study’s authors wrote. “The results justify further studies to optimize therapy outcomes toward clinical translation.”
Starting next year, job seekers in New York City and Nevada will no longer have to worry about whether they’ll flunk a pre-employment drug test — and lose out on a job — because of that joint they smoked the week before.